The expression profile and clinic significance of the SIX family in non-small cell lung cancer
Qian Liu(Sanya University), Kongming Wu(Shanxi Medical University), Yijun Tian(First Affiliated Hospital of Zhengzhou University), Xinwei Han(Columbia University Irving Medical Center), Yu Liu(Peking University), Tengfei Li(United States Food and Drug Administration), Anping Li(Oak Ridge National Laboratory), Jennifer D. Wu(Chang Gung University), Cuntai Zhang(Tongji Hospital)
Cited by 98
Related Papers
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
|Molecular Cancer|2022|1.4k
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
|Molecular Cancer|2019|604
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
|Molecular Cancer|2022|458
An End-to-End Automatic Cloud Database Tuning System Using Deep Reinforcement Learning
|Unknown|2019|309
Chimeric antigen receptor T cells: a novel therapy for solid tumors
|Journal of Hematology & Oncology|2017|306